Lv51
1250 积分 2025-06-24 加入
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
13小时前
已完结
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
1个月前
已完结
Agomelatine in Generalized Anxiety Disorder
3个月前
已关闭
P.4.a.016 Agomelatine in generalized anxiety disorder: a randomized, placebo-controlled, study
3个月前
已关闭
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials
3个月前
已完结
Small molecule approaches to treat autoimmune and inflammatory diseases (Part III): Targeting cytokines and cytokine receptor complexes
5个月前
已完结
Small molecule approaches to treat autoimmune and inflammatory diseases (Part II): Nucleic acid sensing antagonists and inhibitors
5个月前
已完结
Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors
5个月前
已完结
Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies
5个月前
已完结
[Chinese guidelines for diagnosis and treatment of vulvovaginal candidiasis (2024 edition)]
11个月前
已完结
皖公网安备34019202002308
